Table 1 Characteristics of patients and controls
Controls(187) | Sex* | ||
Male, N(%) | 157(83.9%) | ||
Female,(N%) | 30(16.1%) | ||
Mean Age# | 45.5 ± 5.2 | ||
HNSCC & Dysplastic lesions(147) | Sex* | ||
Male, N(%) | 110(74.8%) | ||
Female,(N%) | 37(25.2%) | ||
Mean Age# | 52 ± 6.4 | ||
Lymp Node Positive | 26(17.7%) | ||
Lymp Node Negative | 121(82.3%) | ||
Tobacco User | 103(70%) | ||
Tobacco free | 44(30%) | ||
Alcohol User | 13(8.8%) | ||
Alcohol free | 134(91.2%) | ||
HNSCC (110) | Oral Cavity tumors(85) | Buccal Mucosa, N(%) | 32(29.1%) |
Tongue, N(%) | 13(11.8%) | ||
Cheek, N(%) | 19(17.3%) | ||
Lip, N(%) | 3(2.7%) | ||
Tonsil, N(%) | 4(3.6%) | ||
Palate, N(%) | 2(1.8%) | ||
Alveolus, N(%) | 11(10%) | ||
Vocal cord, N(%) | 1(0.9%) | ||
Laryngeal Tumors(12) & | Larynx, N(%) | 12(10.9%) | |
Nasopharyngeal Tumor(3) | Nassopharynx, N(%) | 3(2.7%) | |
Orofacial Tumors(10) | Maxilla, N(%) | 5(4.5%) | |
Mandible, N(%) | 5(4.5%) | ||
Histopathology(110) | StageI | 15(14%) | |
StageII | 30(27%) | ||
StageIII | 34(31%) | ||
StageIV | 31(28%) | ||
Dysplastic lesions (37) | Buccal Mucosa, N(%) | 37(100%) | |
Histopathology(37) | Mild Dysplasia | 5(13.5%) | |
Moderate Dysplasia | 19(51.4%) | ||
Severe Dysplasia | 13(35.1%) | ||